Symptom relapse following apremilast discontinuation is related to longer disease duration at treatment initiation in patients with moderate-to-severe psoriasis Meeting Abstract

authors

publication date

  • September 1, 2018

webpage

published in

start page

  • AB277

end page

  • AB277

volume

  • 79

issue

  • 3